Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Miao, Yubin; Guo, Haixun

Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Patent · Tue Nov 02 04:00:00 EDT 2021

OSTI ID:1860015

Miao, Yubin; Guo, Haixun

The present invention is directed to novel non-invasive diagnostic tools/compounds comprising a cyclic peptide wherein the compound binds to a MSH receptor to image and treat cancers, especially, melanoma, including metastatic melanoma in vivo. The present invention represents a clear advance in the art which presently relies on tissue biopsy for diagnoses of these cancers. The novel imaging probes are capable of detecting cancerous melanoma cells, as well as their metastatic spread in tissues. This represents a quantum step forward in the diagnosis and treatment of melanoma, including metastatic melanoma using non-invasive molecular imaging techniques. The novel probes of the present invention will also be useful to initiate therapy for melanoma as well as monitor patients response to chemotherapy treatments and other interventions or therapies used in the treatment of melanoma/metastatic melanoma. Compounds according to the present invention may be used as diagnostic tools for a number of conditions and diseases states as well as therapeutic agents for treating such conditions and disease states.

View Patent

Research Organization:: Los Alamos National Laboratory (LANL), Los Alamos, NM (United States); UNM Rainforest Innovations, Albuquerque, NM (United States)

Sponsoring Organization:: USDOE

DOE Contract Number:: AC52-06NA25396

Assignee:: UNM Rainforest Innovations (Albuquerque, NM)

Patent Number(s):: 11,160,887

Application Number:: 16/267,477

OSTI ID:: 1860015

Country of Publication:: United States

Language:: English

References (33)

In Vitro and In Vivo Characterization of Indium-111 and Technetium-99m Labeled CCK-8 Derivatives for CCK-B Receptor Imaging Aloj, L.; Panico, M.; Caraco, C. Cancer Biotherapy and Radiopharmaceuticals, Vol. 19, Issue 1 https://doi.org/10.1089/108497804773391739	journal	February 2004
64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor v 3 Integrin Expression Li, Z. -b.; Cai, W.; Cao, Q. Journal of Nuclear Medicine, Vol. 48, Issue 7 https://doi.org/10.2967/jnumed.107.039859	journal	July 2007
Evaluation of the Human Melanoma Targeting Properties of Radiolabeled α-Melanocyte Stimulating Hormone Peptide Analogues Miao, Yubin; Whitener, Donna; Feng, Weiwei Bioconjugate Chemistry, Vol. 14, Issue 6 https://doi.org/10.1021/bc034069i	journal	October 2003
Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides Dijkgraaf, Ingrid; Kruijtzer, John A. W.; Liu, Shuang European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Issue 2 https://doi.org/10.1007/s00259-006-0180-9	journal	August 2006
Microimaging Characterization of a B16-F10 Melanoma Metastasis Mouse Model Winkelmann, Christopher T.; Figueroa, Said Daibes; Rold, Tammy L. Molecular Imaging, Vol. 5, Issue 2 https://doi.org/10.2310/7290.2006.00011	journal	April 2006
Molecular imaging of gene expression and protein function in vivo with PET and SPECT Sharma, Vijay; Luker, Gary D.; Piwnica-Worms, David Journal of Magnetic Resonance Imaging, Vol. 16, Issue 4 https://doi.org/10.1002/jmri.10182	journal	September 2002
Metastasis Results from Preexisting Variant Cells Within a Malignant Tumor Fidler, Isaiah J.; Kripke, Margaret L. Science, Vol. 197, Issue 4306 https://doi.org/10.1126/science.887927	journal	August 1977
In vivo evaluation of188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy Miao, Yubin; Owen, Nellie K.; Whitener, Donna International Journal of Cancer, Vol. 101, Issue 5 https://doi.org/10.1002/ijc.10640	journal	September 2002
Evaluation of a ^99mTc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin α_vβ₃-Positive Breast Cancer Liu, Shuang; Hsieh, Wen-Yuan; Jiang, Young Bioconjugate Chemistry, Vol. 18, Issue 2 https://doi.org/10.1021/bc0603081	journal	March 2007
Alpha-melanocyte stimulating hormone peptide-targeted melanoma imaging Miao, Yubin Frontiers in Bioscience, Vol. 12, Issue 8-12 https://doi.org/10.2741/2406	journal	January 2007
Impact of PKM Linkers on Biodistribution Characteristics of the ^99mTc-Labeled Cyclic RGDfK Dimer Liu, Shuang; He, Zhengjie; Hsieh, Wen-Yuan Bioconjugate Chemistry, Vol. 17, Issue 6 https://doi.org/10.1021/bc060235l	journal	November 2006
Molecular imaging of cancer with positron emission tomography Gambhir, Sanjiv Sam Nature Reviews Cancer, Vol. 2, Issue 9 https://doi.org/10.1038/nrc882	journal	September 2002
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide Dijkgraaf, Ingrid; Liu, Shuang; Kruijtzer, John A. W. Nuclear Medicine and Biology, Vol. 34, Issue 1 https://doi.org/10.1016/j.nucmedbio.2006.10.006	journal	January 2007
Design of a new class of superpotent cyclic .alpha.-melanotropins based on quenched dynamic simulations Al-Obeidi, Fahad; Hadley, Mac E.; Pettitt, B. Montgomery Journal of the American Chemical Society, Vol. 111, Issue 9 https://doi.org/10.1021/ja00191a044	journal	April 1989
¹¹¹In-Labeled Lactam Bridge-Cyclized α-Melanocyte Stimulating Hormone Peptide Analogues for Melanoma Imaging Miao, Yubin; Gallazzi, Fabio; Guo, Haixun Bioconjugate Chemistry, Vol. 19, Issue 2 https://doi.org/10.1021/bc700317w	journal	January 2008
Tumor-targeting properties of 90Y- and 177Lu-labeled α-melanocyte stimulating hormone peptide analogues in a murine melanoma model Miao, Yubin; Hoffman, Timothy J.; Quinn, Thomas P. Nuclear Medicine and Biology, Vol. 32, Issue 5 https://doi.org/10.1016/j.nucmedbio.2005.03.007	journal	July 2005
Therapeutic Radiopharmaceuticals Volkert, Wynn A.; Hoffman, Timothy J. Chemical Reviews, Vol. 99, Issue 9 https://doi.org/10.1021/cr9804386	journal	September 1999
Imaging of Melanoma Using ⁶⁴Cu− and ⁸⁶Y−DOTA−ReCCMSH(Arg¹¹), a Cyclized Peptide Analogue of α-MSH McQuade, Paul; Miao, Yubin; Yoo, Jeongsoo Journal of Medicinal Chemistry, Vol. 48, Issue 8 https://doi.org/10.1021/jm0490282	journal	March 2005
Melanoma Therapy via Peptide-Targeted -Radiation Miao, Y. Clinical Cancer Research, Vol. 11, Issue 15 https://doi.org/10.1158/1078-0432.CCR-05-0619	journal	August 2005
Design and characterization of -melanotropin peptide analogs cyclized through rhenium and technetium metal coordination Giblin, M. F.; Wang, N.; Hoffman, T. J. Proceedings of the National Academy of Sciences, Vol. 95, Issue 22 https://doi.org/10.1073/pnas.95.22.12814	journal	October 1998
Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models Hoffman, Robert M. The Lancet Oncology, Vol. 3, Issue 9 https://doi.org/10.1016/S1470-2045(02)00848-3	journal	September 2002
Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamics Al-Obeidi, Fahad; Castrucci, Ana M. de L.; Hadley, Mac E. Journal of Medicinal Chemistry, Vol. 32, Issue 12 https://doi.org/10.1021/jm00132a010	journal	December 1989
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System Balch, Charles M.; Soong, Seng-Jaw; Gershenwald, Jeffrey E. Journal of Clinical Oncology, Vol. 19, Issue 16 https://doi.org/10.1200/JCO.2001.19.16.3622	journal	August 2001
Specific Receptors for α-Melanocyte-Stimulating Hormone Are Widely Distributed in Tissues of Rodents Tatro, Jeffrey B.; Reichlin, Seymour Endocrinology, Vol. 121, Issue 5 https://doi.org/10.1210/endo-121-5-1900	journal	November 1987
Design of cyclic and other templates for potent and selective peptide α-MSH analogues Fung, Selena; Hruby, Victor J. Current Opinion in Chemical Biology, Vol. 9, Issue 4 https://doi.org/10.1016/j.cbpa.2005.06.010	journal	August 2005
Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues Miao, Yubin; Fisher, Darrell R.; Quinn, Thomas P. Nuclear Medicine and Biology, Vol. 33, Issue 6 https://doi.org/10.1016/j.nucmedbio.2006.06.005	journal	August 2006
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy Otte, A.; Jermann, E.; Behe, M. European Journal of Nuclear Medicine, Vol. 24, Issue 7 https://doi.org/10.1007/BF00879669	journal	July 1997
Yttrium-90-labelled somatostatin-analogue for cancer treatment Otte, A.; Mueller-Brand, J.; Dellas, S. The Lancet, Vol. 351, Issue 9100 https://doi.org/10.1016/S0140-6736(05)78355-0	journal	February 1998
[ ^99m TcOAADT]-(CH ₂ ) ₂ -NEt ₂ : A Potential Small-Molecule Single-Photon Emission Computed Tomography Probe for Imaging Metastatic Melanoma Cheng, Zhen; Mahmood, Ashfaq; Li, Huazhi Cancer Research, Vol. 65, Issue 12 https://doi.org/10.1158/0008-5472.CAN-03-3093	journal	June 2005
Metastatic melanoma imaging with an 111In-labeled lactam bridge-cyclized α-melanocyte-stimulating hormone peptide Guo, Haixun; Shenoy, Nalini; Gershman, Benjamin M. Nuclear Medicine and Biology, Vol. 36, Issue 3 https://doi.org/10.1016/j.nucmedbio.2009.01.003	journal	April 2009
[half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity. Sawyer, T. K.; Hruby, V. J.; Darman, P. S. Proceedings of the National Academy of Sciences, Vol. 79, Issue 6 https://doi.org/10.1073/pnas.79.6.1751	journal	March 1982
Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases Yang, Meng; Baranov, Eugene; Jiang, Ping Proceedings of the National Academy of Sciences, Vol. 97, Issue 3 https://doi.org/10.1073/pnas.97.3.1206	journal	February 2000
Cancer Statistics, 2007 Jemal, A.; Siegel, R.; Ward, E. CA: A Cancer Journal for Clinicians, Vol. 57, Issue 1 https://doi.org/10.3322/canjclin.57.1.43	journal	January 2007

Similar Records

Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Patent · Tue Apr 23 00:00:00 EDT 2019 · OSTI ID:1568221

Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Patent · Tue Jul 19 00:00:00 EDT 2016 · OSTI ID:1531922

Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment

Journal Article · Thu Nov 07 23:00:00 EST 2013 · Biochemical and Biophysical Research Communications · OSTI ID:22242181

Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Citation Formats

References (33)

Similar Records

Related Subjects